Benedikt Fischer

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 59

Top Topics

Systematic Review

Kidney Transplantation

Transcranial Magnetic Stimulation

Prefrontal Cortex

Top Venues

Drug and alcohol review

Canadian journal of psychiatry. Revue canadienne de psychiatrie

Substance abuse treatment, prevention, and policy

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Tessa Robinson, Forough Farrokhyar, Benedikt Fischer
The associations of supervised consumption services with the rates of opioid-related mortality and morbidity outcomes at the public health unit level in Ontario (Canada): A controlled interrupted time-series analysis. Drug and alcohol review (2024)
Alisa Stampf, Larissa Schwarzkopf, Albert Batalla, Daniel Feingold, Benedikt Fischer, Eva Hoch, null null
Cannabis-related treatment demand at the eve of German cannabis legalization - a 20-years trend analysis. European archives of psychiatry and clinical neuroscience (2024)
Stephanie Coronado-Montoya, Amal Abdel-Baki, David Crockford, José Côté, Simon Dubreucq, Alina Dyachenko, Benedikt Fischer, Tania Lecomte, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Philip Tibbo, Marie Villeneuve, Didier Jutras-Aswad
Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions: A Cross-Sectional Study: Préférences des jeunes adultes souffrant de psychose pour les interventions de réduction des méfaits axées sur le cannabis : une étude transversale. Canadian journal of psychiatry. Revue canadienne de psychiatrie 69 (7) (2024)
Benedikt Fischer, Tessa Robinson
Should cannabis self-cultivation be part of a public health‒oriented legalization policy framework? Canadian journal of public health = Revue canadienne de sante publique (2024)
Benedikt Fischer, Didier Jutras-Aswad, Bernard Le Foll, Tessa Robinson
North America's fentanyl death crisis: Selected lessons for Europe's future? Nordisk alkohol- & narkotikatidskrift : NAT 41 (4) (2024)
Stephanie Coronado-Montoya, Amal Abdel-Baki, David Crockford, José Côté, Simon Dubreucq, Alina Dyachenko, Benedikt Fischer, Tania Lecomte, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Philip Tibbo, Marie Villeneuve, Didier Jutras-Aswad
Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions: A Cross-Sectional Study: Préférences des jeunes adultes souffrant de psychose pour les interventions de réduction des méfaits axées sur le cannabis : une étude transversale. Canadian journal of psychiatry. Revue canadienne de psychiatrie 69 (7) (2024)
Stephanie Coronado-Montoya, Amal Abdel-Baki, David Crockford, José Côté, Simon Dubreucq, Alina Dyachenko, Benedikt Fischer, Tania Lecomte, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Philip Tibbo, Marie Villeneuve, Didier Jutras-Aswad
Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions: A Cross-Sectional Study: Préférences des jeunes adultes souffrant de psychose pour les interventions de réduction des méfaits axées sur le cannabis : une étude transversale. Canadian journal of psychiatry. Revue canadienne de psychiatrie 69 (7) (2024)
Stephanie Coronado-Montoya, Amal Abdel-Baki, David Crockford, José Côté, Simon Dubreucq, Alina Dyachenko, Benedikt Fischer, Tania Lecomte, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Philip Tibbo, Marie Villeneuve, Didier Jutras-Aswad
Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions: A Cross-Sectional Study: Préférences des jeunes adultes souffrant de psychose pour les interventions de réduction des méfaits axées sur le cannabis : une étude transversale. Canadian journal of psychiatry. Revue canadienne de psychiatrie (2024)
Stephanie Coronado-Montoya, Amal Abdel-Baki, David Crockford, José Côté, Simon Dubreucq, Alina Dyachenko, Benedikt Fischer, Tania Lecomte, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Philip Tibbo, Marie Villeneuve, Didier Jutras-Aswad
Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions: A Cross-Sectional Study: Préférences des jeunes adultes souffrant de psychose pour les interventions de réduction des méfaits axées sur le cannabis : une étude transversale. Canadian journal of psychiatry. Revue canadienne de psychiatrie 69 (7) (2024)
Benedikt Fischer, Tessa Robinson, Didier Jutras-Aswad
Three noteworthy idiosyncrasies related to Canada's opioid-death crisis, and implications for public health-oriented interventions. Drug and alcohol review 43 (2) (2023)
Stephanie Coronado-Montoya, Amal Abdel-Baki, José Côté, David Crockford, Simon Dubreucq, Benedikt Fischer, Pamela Lachance-Touchette, Tania Lecomte, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Ovidiu Tatar, Philip G Tibbo, Marie Villeneuve, Anne Wittevrongel, Didier Jutras-Aswad
Evaluation of a Cannabis Harm Reduction Intervention for People With First-Episode Psychosis: Protocol for a Pilot Multicentric Randomized Trial. JMIR research protocols 12 (2023)
Benedikt Fischer, Tessa Robinson, Didier Jutras-Aswad
Three noteworthy idiosyncrasies related to Canada's opioid-death crisis, and implications for public health-oriented interventions. Drug and alcohol review (2023)
Benedikt Fischer, Wayne Hall
Will Germany's new cannabis policy reform plans serve public health? European journal of public health (2023)
Benedikt Fischer, Tessa Robinson, Didier Jutras-Aswad
Three noteworthy idiosyncrasies related to Canada's opioid-death crisis, and implications for public health-oriented interventions. Drug and alcohol review 43 (2) (2023)
Stephanie Coronado-Montoya, Amal Abdel-Baki, José Côté, David Crockford, Simon Dubreucq, Benedikt Fischer, Pamela Lachance-Touchette, Tania Lecomte, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Ovidiu Tatar, Philip G Tibbo, Marie Villeneuve, Anne Wittevrongel, Didier Jutras-Aswad
Evaluation of a Cannabis Harm Reduction Intervention for People With First-Episode Psychosis: Protocol for a Pilot Multicentric Randomized Trial. JMIR research protocols 12 (2023)
Benedikt Fischer
'Drug decriminalization' in Canada: a plea for a nuanced, evidence-informed, and realistic approach towards improved health outcomes. Canadian journal of public health = Revue canadienne de sante publique (2023)
Benedikt Fischer, Tessa Robinson, Didier Jutras-Aswad
Three noteworthy idiosyncrasies related to Canada's opioid-death crisis, and implications for public health-oriented interventions. Drug and alcohol review (2023)
Benedikt Fischer, Tessa Robinson, Didier Jutras-Aswad
Three noteworthy idiosyncrasies related to Canada's opioid-death crisis, and implications for public health-oriented interventions. Drug and alcohol review 43 (2) (2023)
Benedikt Fischer, Wayne Denis Hall, Thiago Marques Fidalgo, Eva Hoch, Bernard Le Foll, María Elena Medina Mora, Jens Reimer, Philip G Tibbo, Didier Jutras-Aswad
Recommendations for Reducing the Risk of Cannabis Use-Related Adverse Psychosis Outcomes: A Public Mental Health-Oriented Evidence Review. Journal of dual diagnosis (2023)
Benedikt Fischer, Tessa Robinson
The marked oscillatory pattern in prescription opioid utilization in Canada since 2000: Selected observations and questions for outcomes and policy. Pharmacoepidemiology and drug safety (2023)
Stephanie Coronado-Montoya, Amal Abdel-Baki, José Côté, David Crockford, Simon Dubreucq, Benedikt Fischer, Pamela Lachance-Touchette, Tania Lecomte, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Ovidiu Tatar, Philip G Tibbo, Marie Villeneuve, Anne Wittevrongel, Didier Jutras-Aswad
Evaluation of a Cannabis Harm Reduction Intervention for People With First-Episode Psychosis: Protocol for a Pilot Multicentric Randomized Trial. JMIR research protocols 12 (2023)
Stephanie Coronado-Montoya, Amal Abdel-Baki, José Côté, David Crockford, Simon Dubreucq, Benedikt Fischer, Pamela Lachance-Touchette, Tania Lecomte, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Ovidiu Tatar, Philip G Tibbo, Marie Villeneuve, Anne Wittevrongel, Didier Jutras-Aswad
Evaluation of a Cannabis Harm Reduction Intervention for People With First-Episode Psychosis: Protocol for a Pilot Multicentric Randomized Trial. JMIR research protocols 12 (2023)
Benedikt Fischer, Tessa Robinson, Didier Jutras-Aswad
Three noteworthy idiosyncrasies related to Canada's opioid-death crisis, and implications for public health-oriented interventions. Drug and alcohol review 43 (2) (2023)
Benedikt Fischer, Tessa Robinson
The marked oscillatory pattern in prescription opioid utilization in Canada since 2000: Selected observations and questions for outcomes and policy. Pharmacoepidemiology and drug safety 33 (1) (2023)
Benedikt Fischer, Tessa Robinson
The marked oscillatory pattern in prescription opioid utilization in Canada since 2000: Selected observations and questions for outcomes and policy. Pharmacoepidemiology and drug safety 33 (1) (2023)
Himani Boury, Wayne Denis Hall, Benedikt Fischer
Developments and Changes in Primary Public Health Outcome Indicators Associated with the Legalization of Non-Medical Cannabis Use and Supply in Canada (2018): A Comprehensive Overview. International journal of mental health and addiction (2022)
Jackson P Loyal, Miriam Ruth Lavergne, Mehdi Shirmaleki, Benedikt Fischer, Ridhwana Kaoser, Jack Makolewksi, Will Small
Trends in Involuntary Psychiatric Hospitalization in British Columbia: Descriptive Analysis of Population-Based Linked Administrative Data from 2008 to 2018. Canadian journal of psychiatry. Revue canadienne de psychiatrie (2022)
Tessa Robinson, Muhammad Usman Ali, Bethany Easterbrook, Wayne Denis Hall, Didier Jutras-Aswad, Benedikt Fischer
Risk-thresholds for the association between frequency of cannabis use and the development of psychosis: a systematic review and meta-analysis. Psychological medicine (2022)
David Rudoler, Paul Kurdyak, Tara Gomes, Anjie Huang, Wayne Jones, Stephanie Littleford, Nabiha Paracha, Benedikt Fischer
Evaluating the population-level effects of oxycodone restrictions on prescription opioid utilization in Ontario. Pharmacoepidemiology and drug safety 31 (7) (2022)
Cayley Russell, Michelle Pang, Frishta Nafeh, Shanna Farrell Macdonald, Dena Derkzen, Jürgen Rehm, Benedikt Fischer
Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada. International journal of qualitative studies on health and well-being 17 (1) (2022)
Dimitri Daldegan-Bueno, Sheila Rubia Lindner, Douglas Francisco Kovaleski, Benedikt Fischer
Cannabis use, risk behaviours and harms in Brazil: A comprehensive review of available data indicators. Drug and alcohol review (2022)
Himani Boury, Wayne Denis Hall, Benedikt Fischer
Developments and Changes in Primary Public Health Outcome Indicators Associated with the Legalization of Non-Medical Cannabis Use and Supply in Canada (2018): A Comprehensive Overview. International journal of mental health and addiction (2022)
Daniel Werb, Ayden I Scheim, Ayorinde Soipe, Samantha Aeby, Indhu Rammohan, Benedikt Fischer, Scott E Hadland, Brandon D L Marshall
Health harms of non-medical prescription opioid use: A systematic review. Drug and alcohol review 41 (4) (2022)
Karen Lorena N Baia, Ana Caroline C Cordeiro, Paula Cristina R Frade, Alanna Gabrielly N Gouveia, Rafael Lima Resque, Luiz Marcelo L Pinheiro, Ricardo Roberto de Souza Fonseca, Luiz Fernando Almeida Machado, Luísa Caricio Martins, Emil Kupek, Benedikt Fischer, Aldemir Branco de Oliveira Filho
Syphilis and Co-Infections with HIV-1, HBV, and HCV among People Who Use Crack-Cocaine in Northern Brazil. Pathogens (Basel, Switzerland) 11 (9) (2022)
Dimitri Daldegan-Bueno, Sheila Rubia Lindner, Benedikt Fischer
Conceptualizing and considering Cannabis-Related "Harm-to-Others": The Role of Cannabis-Related Violence. Substance use & misuse 57 (9) (2022)
Wayne Jones, Ridhwana Kaoser, David Rudoler, Benedikt Fischer
Trends in dispensing of individual prescription opioid formulations, Canada 2005-2020. Journal of pharmaceutical policy and practice 15 (1) (2022)
Wayne Jones, Ridhwana Kaoser, Benedikt Fischer
Patterns, trends and determinants of medical opioid utilization in Canada 2005-2020: characterizing an era of intensive rise and fall. Substance abuse treatment, prevention, and policy 16 (1) (2021)
Benedikt Fischer, Angelica Lee, Tessa Robinson, Wayne Hall
An overview of select cannabis use and supply indicators pre- and post-legalization in Canada. Substance abuse treatment, prevention, and policy 16 (1) (2021)
Benedikt Fischer, Neil Boyd, Serge Brochu
Proposals for Decriminalization of Illicit Drug Use: Considering a Combination of déjà-vu, Diversion and Devil-with-many-details for Health-oriented Policy Reform. Canadian journal of psychiatry. Revue canadienne de psychiatrie (2021)
Raquel Silva do Nascimento, Karen Lorena N Baia, Samara Borges de Souza, Guilherme Martins Gomes Fontoura, Patrícia Ferreira Nunes, Luiz Fernando Almeida Machado, Emil Kupek, Benedikt Fischer, Luísa Caricio Martins, Aldemir Branco de Oliveira Filho
Hepatitis E Virus in People Who Use Crack-Cocaine: A Cross-Sectional Study in a Remote Region of Northern Brazil. Viruses 13 (5) (2021)
Ronylson José S Silva, Raquel Silva do Nascimento, José Augusto J Oliveira-Neto, Fabricio Quaresma Silva, Juliana Nádia F Piauiense, Camila Moraes Gomes, Luiz Marcelo L Pinheiro, Rafael Lima Resque, João Renato Rebello Pinho, Emil Kupek, Benedikt Fischer, Luiz Fernando Almeida Machado, Luísa Caricio Martins, José Alexandre R Lemos, Aldemir Branco de Oliveira Filho
Detection and Genetic Characterization of Hepatitis B and D Viruses: A Multi-Site Cross-Sectional Study of People Who Use Illicit Drugs in the Amazon Region. Viruses 13 (7) (2021)
Benedikt Fischer, Caroline O'Keefe-Markman, Angelica Min-Hye Lee, Dimitri Daldegan-Bueno
'Resurgent', 'twin' or 'silent' epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America. Substance abuse treatment, prevention, and policy 16 (1) (2021)
Benedikt Fischer, Evan Wood
A decade of extreme oscillations in opioid control and availability: implications for public health in a Canadian setting. Journal of public health policy 41 (2) (2021)
Lucas Oliveira Maia, Dimitri Daldegan-Bueno, Benedikt Fischer
Opioid use, regulation, and harms in Brazil: a comprehensive narrative overview of available data and indicators. Substance abuse treatment, prevention, and policy 16 (1) (2021)
Dimitri Daldegan-Bueno, Lucas Oliveira Maia, Michelle Glass, Didier Jutras-Aswad, Benedikt Fischer
Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies. Psychopharmacology (2021)
Benedikt Fischer, Monica Malta, Guilherme Messas, Marcelo Ribeiro
Introducing the evidence-based population health tool of the Lower-Risk Cannabis Use Guidelines to Brazil. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 41 (6) (2020)
Benedikt Fischer, Dimitri Daldegan-Bueno, Joseph M Boden
Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, concepts and considerations. Drug and alcohol review 39 (5) (2020)
Stephanie Lake, Thomas Kerr, Daniel Werb, Rebecca J Haines-Saah, Benedikt Fischer, Gerald Thomas, Zach Walsh, Mark A Ware, Evan Wood, Michael John Milloy
Guidelines for public health and safety metrics to evaluate the potential harms and benefits of cannabis regulation in Canada. Drug and alcohol review 38 (6) (2020)
Benedikt Fischer
Some notes on the use, concept and socio-political framing of 'stigma' focusing on an opioid-related public health crisis. Substance abuse treatment, prevention, and policy 15 (1) (2020)
Benedikt Fischer, Wayne Jones, Mark Tyndall, Paul Kurdyak
Correlations between opioid mortality increases related to illicit/synthetic opioids and reductions of medical opioid dispensing - exploratory analyses from Canada. BMC public health 20 (1) (2020)
Benedikt Fischer, Dimitri Daldegan-Bueno, Wayne Jones
Comparison of Crude Population-Level Indicators of Opioid Use and Related Harm in New Zealand and Ontario (Canada). Pain and therapy 10 (1) (2020)
Benedikt Fischer, Michelle Pang, Wayne Jones
The opioid mortality epidemic in North America: do we understand the supply side dynamics of this unprecedented crisis? Substance abuse treatment, prevention, and policy 15 (1) (2020)
Wayne Jones, Lenka Vojtila, Paul Kurdyak, Benedikt Fischer
Prescription opioid dispensing in Canada: an update on recent developments to 2018. Journal of pharmaceutical policy and practice 13 (2020)
Wayne Jones, Paul Kurdyak, Benedikt Fischer
Examining correlations between opioid dispensing and opioid-related hospitalizations in Canada, 2007-2016. BMC health services research 20 (1) (2020)
Benedikt Fischer, Christopher R Bullen, Wayne Denis Hall
A call for greater policy and regulatory coherence for an expanding menu of legal psychoactive substances. Drug and alcohol review 39 (6) (2020)
Monica Malta, Thepikaa Varatharajan, Cayley Russell, Michelle Pang, Sarah Bonato, Benedikt Fischer
Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review. PLoS medicine 16 (12) (2019)
Benedikt Fischer, Amanda Butler, Cayley Russell
Commentary on Fazel et al. (2017): High levels of substance use disorders among correctional inmates-some implications for interventions of the review data from Fazel et al. Addiction (Abingdon, England) 112 (10) (2019)
Benedikt Fischer, Paul Kurdyak, Wayne Jones
Tramadol dispensing patterns and trends in Canada, 2007-2016. Pharmacoepidemiology and drug safety 28 (3) (2018)
Benedikt Fischer, Lenka Vojtila, Paul Kurdyak
'Delisting' OxyContin® to reduce prescription opioid-related harms in Ontario (Canada)-gauging effects 5 years later. Pharmacoepidemiology and drug safety 26 (9) (2017)